Press Release - On 13 and 20 July 2021, the COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS) met virtually to discuss rare reports of Guillain-Barré Syndrome (GBS) following vaccination with the Janssen and AstraZeneca COVID-19 vaccines. Both vaccines use an adenovirus platform as their backbone.
